Pericytes: A double-edged sword in cancer therapy

Mao Bin Meng, Nicholas G. Zaorsky, Lei Deng, Huan Huan Wang, Jiang Chao, Lu Jun Zhao, Zhi Yong Yuan, Wang Ping

Research output: Contribution to journalReview articlepeer-review

37 Scopus citations

Abstract

Pericytes, which envelope the vascular endothelium throughout the body, are often targeted to promote vascular normalization and restore normal function of blood vessels in cancer treatment. The goals of pericyte-targeted therapy tend to promote proper vascular normalization of the tumor. Tumor vascular normalization prevents metastasis, increases tumor oxygenation (making radiation more effective in killing tumor cells), optimizes Starling forces to increase delivery of cancer cell-directed therapies (e.g., chemotherapy or targeted agents), increases the efficacy of focal therapies (e.g., surgery or radiation), and increases recognition by the host immune system. We review how approaches in pericyte-targeted therapy aim to reach a balance between pro-angiogenic and anti-angiogenic function (i.e., by targeting platelet-derived growth factor beta receptors, vascular endothelial growth factor receptors and Tie-2) for tumor vascular normalization.

Original languageEnglish (US)
Pages (from-to)169-179
Number of pages11
JournalFuture Oncology
Volume11
Issue number1
DOIs
StatePublished - Jan 1 2015

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'Pericytes: A double-edged sword in cancer therapy'. Together they form a unique fingerprint.

Cite this